Form 4: Pulmonx Corp Executive Lehman David Aaron Reports Stock Transactions
SEC Form 4
General Counsel David Aaron Lehman of Pulmonx Corp reports the sale of common stock to cover tax obligations and the acquisition of restricted stock units and stock options.
Summary
- On March 1, 2024, David Aaron Lehman, General Counsel of Pulmonx Corp, reported the sale of 4,351 shares of common stock in three separate transactions at a price of $9.06 per share.
- These sales were to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs) granted on June 1, 2021, March 1, 2022, and March 1, 2023.
- Lehman also acquired 34,500 shares in the form of RSUs, which vest over four years in equal quarterly installments starting March 1, 2024.
- Additionally, Lehman acquired options to purchase 69,100 shares of common stock at an exercise price of $9.30, vesting in 48 equal monthly installments beginning March 1, 2024.
- Following these transactions, Lehman directly owns 179,988 shares of Pulmonx Corp common stock and holds options for 69,100 shares.
Sentiment
Score: 6
Explanation: Neutral sentiment. The filing reflects routine transactions related to executive compensation and tax obligations. There are no explicit positive or negative indicators for the company's overall performance.
Positives
- The grant of RSUs and stock options to the General Counsel suggests continued alignment of interests between management and shareholders.
- The vesting schedules of the RSUs and stock options incentivize long-term performance.
Negatives
- The sale of shares to cover tax obligations, while common, slightly reduces the executive's holdings.
Risks
- Future sales of shares by the reporting person could exert downward pressure on the stock price.
Future Outlook
The document does not contain explicit forward-looking statements, but the vesting schedules of the RSUs and stock options suggest a commitment to the company's future.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives.
Comparison to Industry Standards
- Stock option and RSU grants are standard compensation practices for executives in publicly traded companies, aligning their interests with those of shareholders.
- Vesting schedules are also typical, encouraging long-term commitment and performance.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding executive compensation and stock ownership.
- The vesting schedules incentivize the executive to contribute to the company's long-term success, benefiting shareholders.
Key Dates
| Date | Description |
|---|---|
| 06/01/2021 | Date of RSU grant related to tax obligations covered by stock sales. |
| 03/01/2022 | Date of RSU grant related to tax obligations covered by stock sales. |
| 03/01/2023 | Date of RSU grant related to tax obligations covered by stock sales. |
| 03/01/2024 | Date of transactions: stock sales, RSU grant, and stock option grant; also the start date for vesting of RSUs and stock options. |
| 02/28/2034 | Expiration date of the employee stock options. |
| 03/05/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.